Ether phospholipids metabolism is a latent vulnerability for pancreatic cancer resistance

Authors

Ziheng Chen, The University of Texas MD Anderson Cancer Center
I-Lin Ho, The University of Texas MD Anderson Cancer Center
Liang Yan, The University of Texas MD Anderson Cancer Center
Shujuan Chen, The University of Texas MD Anderson Cancer Center
Melinda Soeung, The University of Texas MD Anderson Cancer Center
Johnathon L. Rose, The University of Texas MD Anderson Cancer Center
Sanjana Srinivasan, The University of Texas MD Anderson Cancer Center
Andrea Viale, The University of Texas MD Anderson Cancer Center
Alessandro Carugo, The University of Texas MD Anderson Cancer Center
Giannicola Genovese, The University of Texas MD Anderson Cancer Center
Wantong Yao MD, PhD, The University of Texas MD Anderson Cancer Center
Ningping Feng, The University of Texas MD Anderson Cancer Center
Jason P. Gay, The University of Texas MD Anderson Cancer Center
Joeeph Marszalek, The University of Texas MD Anderson Cancer Center
Haoqiang Ying, The University of Texas MD Anderson Cancer Center
Giulio Draetta, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00047

Publication Date

2022

Department

Genomic Medicine

Research Category

Other

Recommended Citation

Chen, Ziheng; Ho, I-Lin; Yan, Liang; Chen, Shujuan; Soeung, Melinda; Rose, Johnathon L.; Srinivasan, Sanjana; Viale, Andrea; Carugo, Alessandro; Genovese, Giannicola; Yao, Wantong MD, PhD; Feng, Ningping; Gay, Jason P.; Marszalek, Joeeph; Ying, Haoqiang; and Draetta, Giulio, "Ether phospholipids metabolism is a latent vulnerability for pancreatic cancer resistance" (2022). Leading Edge of Cancer Research Symposium. 63.
doi:https://doi.org/10.52519/00047